SFX by Ex Libris Inc.

Title:	Control of autoimmune diabetes in NOD mice by GAD expression or suppression in beta cells
Source:	Science [0036-8075] Yoon, J W yr:1999

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Roncarolo, M. "Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans." Nature reviews. Immunology 7.8 (2007): 585-98.
description	2.	Harrison, Leonard C. "Antigen-Based Vaccination and Prevention of Type 1 Diabetes." Current diabetes report 13.5 (2013): 616-623.
description	3.	Ludvigsson, J. "Therapy with GAD in diabetes." Diabetes/metabolism research and reviews 25.4 (2009): 307-15.
description	4.	Iwakoshi, N. "Treatment of allograft recipients with donor-specific transfusion and anti-CD154 antibody leads to deletion of alloreactive CD8(+) T cells and prolonged craft survival in a CTLA4-dependent manner." The journal of immunology 164.1 (2000): 512-521.
description	5.	Faresjö MK, J. "Diminished IFN-gamma response to diabetes-associated autoantigens in children at diagnosis and during follow up of type 1 diabetes." Diabetes/metabolism research and reviews 22.6 (2006): 462-70.
description	6.	Morelli, Adrian E E. "Tolerogenic dendritic cells and the quest for transplant tolerance." Nature reviews. Immunology 7.8 (2007): 610-21.
description	7.	Forbes, Josephine M. "Mitochondrial dysfunction in diabetic kidney disease." Nature reviews. Nephrology 14.5 (2018): 291-312.
description	8.	Iranzo, A. "Parkinson disease and sleep: sleep-wake changes in the premotor stage of Parkinson disease; impaired olfaction and other prodromal features." Current neurology and neuroscience reports 13.9 (2013): 373-373.
description	9.	Zammit, Nathan W. "Low-Dose Rapamycin Unmasks the Protective Potential of Targeting Intragraft NF-κB for Islet Transplants." Cell transplantation 22.12 (2012): 2355-66.
description	10.	Reddy, Mv Prasad Linga P. "Association between type 1 diabetes and GWAS SNPs in the southeast US Caucasian population." Genes and Immunity 12.3 (2011): 208-212.
description	11.	Lu, L. "Blockade of the CD40-CD40 ligand pathway potentiates the capacity of donor-derived dendritic cell progenitors to induce long-term cardiac allograft survival." Transplantation 64.12 (1997): 1808-1815.
description	12.	Vendrame, F. "Recurrence of Type 1 Diabetes after Simultaneous Pancreas-Kidney." Diabetes (2010).
description	13.	Shi, Y. "Increased expression of GAD65 and GABA in pancreatic beta-cells impairs first-phase insulin secretion." American journal of physiology: endocrinology and metabolism 279.3 (2000): 684-94.
description	14.	Harrison, L C. "Vaccination against self to prevent autoimmune disease: the type 1." Immunology and cell biology 86.2 (2008): 139-.
description	15.	Uibo, R. "GAD65 autoimmunity-clinical studies." Adv Immunol 100 (2008): 39-78.
description	16.	van Endert, P. "HLA class I epitope discovery in type 1 diabetes." Annals of the New York Academy of Sciences 1079.Immunology of Diabetes IV (2006): 190-7.
description	17.	Betterle, C. "Clinical and subclinical organ-specific autoimmune manifestations in type 1 (insulin-dependent) diabetic patients and their first-degree relatives." Diabetologia 26.6 (1984): 431-6.
description	18.	Rossini, A A A. "Prolonged survival of mouse skin allografts in recipients treated with donor splenocytes and antibody to CD40 ligand." Transplantation 64.2 (1997): 329-35.
description	19.	Höglund, P. "Initiation of autoimmune diabetes by developmentally regulated presentation of islet cell antigens in the pancreatic lymph nodes." The Journal of experimental medicine 189.2 (1999): 331-9.
description	20.	Faria, Ana M C M. "Oral tolerance: therapeutic implications for autoimmune diseases." Clinical & developmental immunology 13.2-4 (2006): 143-57.